株式会社タウンズ · TAUNS Laboratories,Inc.
| Revenue | ¥18.6B |
|---|---|
| Operating income | ¥8.3B |
| Net income | ¥6.3B |
| Free cash flow | ¥1.6B |
| Operating margin | 44.4% |
| Net margin | 33.9% |
| Return on equity | 36.3% |
| Period | 2025 |
| Revenue | ¥18.6B |
|---|---|
| Operating income | ¥8.3B |
| Net income | ¥6.3B |
| Free cash flow | ¥1.6B |
| Operating margin | 44.4% |
| Net margin | 33.9% |
| Return on equity | 36.3% |
| Period | 2025 |